The paper's citation list

Patient-derived xenografts or organoids in the discovery of traditional and self-assembled drug for tumor immunotherapy. 2023;13: doi: 10.3389/fonc.2023.1122322

Neurologische Nebenwirkungen von Checkpoint-Inhibitoren. 2019;90:138 doi: 10.1007/s00115-018-0571-8

Immunotherapeutic Strategies in Cancer and Atherosclerosis—Two Sides of the Same Coin. 2022;8: doi: 10.3389/fcvm.2021.812702

Bacterial membrane vesicles combined with nanoparticles for bacterial vaccines and cancer immunotherapy. 2024;243:114125 doi: 10.1016/j.colsurfb.2024.114125

Recent Progress of Alkyl Radicals Generation‐Based Agents for Biomedical Applications. 2021;10: doi: 10.1002/adhm.202100055

Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast. 2023;15:1836 doi: 10.3390/cancers15061836

Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies. 2023;12:841 doi: 10.3390/cells12060841

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments. 2023;21: doi: 10.1186/s12967-023-04292-3

Handbook of Cancer and Immunology. 2023;1 doi: 10.1007/978-3-030-80962-1_180-1

Applications of CRISPR Epigenome Editors in Tumor Immunology and Autoimmunity. 2024;13:413 doi: 10.1021/acssynbio.3c00524

Immunotherapy approaches for hematological cancers. 2022;25:105326 doi: 10.1016/j.isci.2022.105326

Immunocompetent cancer-on-chip models to assess immuno-oncology therapy. 2021;173:281 doi: 10.1016/j.addr.2021.03.015

Cancer immunotherapy. 2021;17:834 doi: 10.4103/jcrt.JCRT_1241_20

Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. 2022;9:327 doi: 10.3390/vetsci9070327

Aptamers in cancer therapy: problems and new breakthroughs. 2023;11:1609 doi: 10.1039/D2TB02579E

Systems Medicine. 2021;593 doi: 10.1016/B978-0-12-801238-3.11605-8

CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach. 2023;21: doi: 10.1186/s12951-023-01900-8

Targeting Immune Checkpoint Pathways in Melanoma: Triumphs and Challenges. 2023;5: doi: 10.4155/fdd-2022-0010

Cell Interaction - Molecular and Immunological Basis for Disease Management. 2021; doi: 10.5772/intechopen.94560

A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures. 2022;103:108433 doi: 10.1016/j.intimp.2021.108433

Immunotherapies and Combination Strategies for Immuno-Oncology. 2020;21:5009 doi: 10.3390/ijms21145009

Novel Clinical Trial Designs and Statistical Methods in the Era of Precision Medicine. 2021;13:133 doi: 10.1080/19466315.2020.1814403

CAR-T Cell Therapy for Cancer. 2024;6:21 doi: 10.54133/ajms.v6i2.726

Understanding Cancer. 2022;269 doi: 10.1016/B978-0-323-99883-3.00004-4

MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer. 2019;303:223 doi: 10.1016/j.jconrel.2019.04.019

Systemic anticancer therapies and the role of primary care. 2020;31:22 doi: 10.1002/psb.1871

Reference Module in Biomedical Sciences. 2024; doi: 10.1016/B978-0-323-95488-4.00058-9

Activation of T Lymphocytes with Anti‐PDL1‐BiTE in the Presence of Adipose‐Derived Mesenchymal Stem Cells (ASCs). 2023;2023: doi: 10.1155/2023/7692726

Immunotherapy – A Novel Facet of Modern Therapeutics. 2021;1 doi: 10.1007/978-981-15-9038-2_1

ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer. 2021;9:7435 doi: 10.1039/D1TB01408K

Pyroptosis: A road to next-generation cancer immunotherapy. 2023;68:101782 doi: 10.1016/j.smim.2023.101782

Tumor Innervation: History, Methodologies, and Significance. 2022;14:1979 doi: 10.3390/cancers14081979

Steering the course of CAR T cell therapy with lipid nanoparticles. 2024;22: doi: 10.1186/s12951-024-02630-1

Drug Delivery Devices and Therapeutic Systems. 2021;423 doi: 10.1016/B978-0-12-819838-4.00016-X

Biomedical Translational Research. 2022;413 doi: 10.1007/978-981-16-8845-4_21

Delivery of a Cancer-Testis Antigen-Derived Peptide Using Conformationally Restricted Dipeptide-Based Self-Assembled Nanotubes. 2021;18:3832 doi: 10.1021/acs.molpharmaceut.1c00451

Durability of Response in Metastatic Melanoma Patients after Combined Treatment with Radiation Therapy and Ipilimumab. 2020;7: doi: 10.2217/mmt-2019-0020

The discovery of potent small molecule activators of human STING. 2021;209:112869 doi: 10.1016/j.ejmech.2020.112869

Nanotherapeutics in Cancer Vaccination and Challenges. 2022;29 doi: 10.1016/B978-0-12-823686-4.00018-5

The need for rapid therapeutic efficacy testing for cancer therapy. 2020;113:104382 doi: 10.1016/j.yexmp.2020.104382

Emerging therapeutic agents for advanced non-small cell lung cancer. 2020;13: doi: 10.1186/s13045-020-00881-7

Immuno-oncological Challenges and Chemoresistance in Veterinary Medicine: Probiotics as a New Strategic Tool. 2025; doi: 10.1007/s12602-025-10468-8

Molecular and Cell Biology of Cancer. 2019;117 doi: 10.1007/978-3-030-11812-9_7

The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives. 2024;20:51 doi: 10.14216/kjco.24009

Nano-ablative immunotherapy for cancer treatment. 2021;10:3247 doi: 10.1515/nanoph-2021-0171

Quantification and functional assessment of antigen(-) tumor cell variants. 2025; doi: 10.1016/bs.mcb.2025.03.012

Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment. 2022;22 doi: 10.37349/emed.2022.00072

Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy. 2022;14:2606 doi: 10.3390/pharmaceutics14122606

Current Applications for Overcoming Resistance to Targeted Therapies. 2019;20:97 doi: 10.1007/978-3-030-21477-7_4

Advances in Immunology and Immuno-techniques. 2024;1 doi: 10.1007/978-981-97-5508-0_1

Th1 cytokines in conjunction with pharmacological Akt inhibition potentiate apoptosis of breast cancer cells in vitro and suppress tumor growth in vivo. 2020;11:2873 doi: 10.18632/oncotarget.27556

Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome accelerates bio-therapeutic threshold of apigenin in neoplastic rat liver: a mechanistic approach. 2023;21: doi: 10.1186/s12951-022-01764-4

Human health and snails. 2021;42:211 doi: 10.1080/15321819.2020.1844751

The Microbiome in Health and Disease. 2020;171:301 doi: 10.1016/bs.pmbts.2020.04.004

Chimeric Antigen Receptor T-Cell Therapy. 2021;6:118 doi: 10.4103/gjtm.gjtm_88_21

Handbook on Synthesis Strategies for Advanced Materials. 2021;643 doi: 10.1007/978-981-16-1892-5_14

Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities. 2024;9: doi: 10.1038/s41392-024-01826-z

A novel electrochemical sensor based on CuCo2O4/NCNTs modified glassy carbon electrode for simultaneous determination of 6-thioguanine and dasatinib in biological samples. 2025;434:127889 doi: 10.1016/j.molliq.2025.127889

Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease. 2023;29:248 doi: 10.1097/MCP.0000000000000975

Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy. 2022;345:586 doi: 10.1016/j.jconrel.2022.03.045

Hoffbrand's Postgraduate Haematology. 2025;82 doi: 10.1002/9781119706687.ch6

New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors. 2022;24:651 doi: 10.1007/s11912-022-01218-y

The Intriguing History of Cancer Immunotherapy. 2019;10: doi: 10.3389/fimmu.2019.02965

Immunotherapies for hepatocellular carcinoma. 2022;11:571 doi: 10.1002/cam4.4468

Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment. 2020;16:62 doi: 10.2174/1573394715666190913184853

Advanced Fermentation and Cell Technology. 2021;579 doi: 10.1002/9781119042792.part3

Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease. 2020;12:1649 doi: 10.3390/cancers12061649

Immunotherapy. 2020;1244:255 doi: 10.1007/978-3-030-41008-7_13

Immunotherapy. 2021;25:371 doi: 10.4103/0973-029X.325257

Drug Repurposing for Triple-Negative Breast Cancer. 2020;10:200 doi: 10.3390/jpm10040200

Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy. 2024;208:107352 doi: 10.1016/j.phrs.2024.107352

A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review). 2022;48: doi: 10.3892/or.2022.8405

Medicinal Chemistry of Anticancer Drugs. 2023;681 doi: 10.1016/B978-0-12-818549-0.00014-5

Understanding immunotherapy and its management. 2021;001 doi: 10.17352/2455-8591.000030

Highlights into historical and current immune interventions for cancer. 2023;117:109882 doi: 10.1016/j.intimp.2023.109882

Investigation of the Relationship Between DNA Mismatch Repair Genes and Microsatellite Instability in Solid Tumors. 2024;34:689 doi: 10.54005/geneltip.1510108

Recent Progress in the Synergistic Combination of Nanoparticle‐Mediated Hyperthermia and Immunotherapy for Treatment of Cancer. 2021;10: doi: 10.1002/adhm.202001415

A Hepatitis B Virus-Derived Peptide Exerts an Anticancer Effect via TNF/iNOS-producing Dendritic Cells in Tumor-Bearing Mouse Model. 2021;13:407 doi: 10.3390/cancers13030407

Emerging Trends in Immunotherapy for Cancer. 2022;10:60 doi: 10.3390/diseases10030060

Immunotherapy: An emerging treatment option for neurodegenerative diseases. 2024;29:103974 doi: 10.1016/j.drudis.2024.103974

Immunotherapy. 2018;995:131 doi: 10.1007/978-3-030-02505-2_6

Multiple White Plaques in the Esophagus: A Possible Case of Esophageal Mucosal Alteration Associated With Immune-Related Adverse Events of Immune Checkpoint Inhibitors. 2022; doi: 10.7759/cureus.32710

Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB. 2023;14: doi: 10.3389/fimmu.2023.1129323

Exosomes Represent an Immune Suppressive T Cell Checkpoint in Human Chronic Inflammatory Microenvironments. 2020;49:726 doi: 10.1080/08820139.2020.1748047

Editorial. 2019;12:3 doi: 10.1111/ors.12402

Construction of a prognostic model for gastric cancer based on immune infiltration and microenvironment, and exploration of MEF2C gene function. 2025;18: doi: 10.1186/s12920-024-02082-4

Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy. 2024;37:101568 doi: 10.1016/j.beha.2024.101568

Aptamers as an approach to targeted cancer therapy. 2024;24: doi: 10.1186/s12935-024-03295-4

Toll‑like receptor 3 ligands for breast cancer therapies (Review). 2023;19: doi: 10.3892/mco.2023.2656

Immunotherapy for HER2-Positive Breast Cancer: Changing the Paradigm. 2019;11:248 doi: 10.1007/s12609-019-00332-4

The exploitation of enzyme-based cancer immunotherapy. 2022;36:98 doi: 10.1007/s13577-022-00821-2

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects. 2023;15:1063 doi: 10.3390/cancers15041063

Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer. 2019;9: doi: 10.3389/fonc.2019.00396

Trends in Biomathematics: Stability and Oscillations in Environmental, Social, and Biological Models. 2022;225 doi: 10.1007/978-3-031-12515-7_12

Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms. 2021;22:1301 doi: 10.1007/s10198-021-01337-6

On the very idea of pursuitworthiness. 2022;91:103 doi: 10.1016/j.shpsa.2021.11.016

Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells. 2020;37:354 doi: 10.1016/j.ccell.2020.02.001

Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?. 2020;34:749 doi: 10.1007/s40259-020-00450-x

Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management. 2020;52:402 doi: 10.4103/ijp.IJP_475_18

A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy. 2019;18:1081 doi: 10.1158/1535-7163.MCT-18-0737

B cell-rich niches support stem-like CD8+ T cells in cancer microenvironment. 2023;41:824 doi: 10.1016/j.ccell.2023.04.007

Modern therapies of nonsmall cell lung cancer. 2023;64:695 doi: 10.1007/s13353-023-00786-4

Cancer Immunotherapy: A Brief History, The Latest Development of Typical Subtypes and Therapy Combination. 2023;30:34 doi: 10.54097/hset.v30i.4943

A comprehensive review of immune checkpoint inhibitors for cancer treatment. 2024;143:113365 doi: 10.1016/j.intimp.2024.113365

The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy. 2022;29: doi: 10.1186/s12929-022-00796-0

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. 2020;10:666 doi: 10.3390/biom10050666

RNA methylation and cellular response to oxidative stress-promoting anticancer agents. 2023;22:870 doi: 10.1080/15384101.2023.2165632

Immunity Management Post Cancer Therapy. 2022;24 doi: 10.52711/2231-5691.2022.00005

Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer. 2023;15:1412 doi: 10.3390/cancers15051412

Novel therapeutic strategies for spinal osteosarcomas. 2020;64:83 doi: 10.1016/j.semcancer.2019.05.018

Spontaneous regression of adenocarcinoma of submandibular gland. 2021;87:486 doi: 10.1016/j.bjorl.2020.10.014

Recent progress in cancer immunotherapy: Overview of current status and challenges. 2023;241:154241 doi: 10.1016/j.prp.2022.154241

Tumor-associated macrophages: Shifting bad prognosis to improved efficacy in cancer therapies?. 2021;015 doi: 10.17352/2455-8591.000032

Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. 2024;30:1018 doi: 10.1093/ibd/izad229

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines. 2020;12:270 doi: 10.3390/v12030270

Recent developments in antibody derivatives against colorectal cancer; A review. 2021;265:118791 doi: 10.1016/j.lfs.2020.118791

Cancer: The Enemy from Within. 2020;223 doi: 10.1007/978-3-030-40651-6_9

Learning-accelerated discovery of immune-tumour interactions. 2019;4:747 doi: 10.1039/C9ME00036D

Antitumour metastasis and the antiangiogenic and antitumour effects of a Eimeria stiedae soluble protein. 2021;43: doi: 10.1111/pim.12825

Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T. 2020;112:562 doi: 10.1093/jnci/djaa021

Immunotherapy. 2021;1342:357 doi: 10.1007/978-3-030-79308-1_14

Immunotherapy: Magic Bullet to Change the Future Therapeutics. 2025;144:1 doi: 10.1016/bs.apcsb.2024.10.015

Resistance to Targeted Therapies in Lymphomas. 2019;21:155 doi: 10.1007/978-3-030-24424-8_7

Molecular Targets in Cancer Therapy. 2025;241 doi: 10.1007/978-981-96-7336-0_11

Molecular Stacking Composite Nanoparticles of Gossypolone and Thermodynamic Agent for Elimination of Large Tumor in Mice via Electrothermal‐Thermodynamic‐Chemo Trimodal Combination Therapy. 2022;32: doi: 10.1002/adfm.202201666

Current trends in cancer immunotherapy: a literature-mining analysis. 2020;69:2425 doi: 10.1007/s00262-020-02630-8

Overview of Current Immunotherapies Targeting Mutated KRAS Cancers. 2019;19:2158 doi: 10.2174/1568026619666190904163524

Redrawing therapeutic boundaries: microbiota and cancer. 2022;8:87 doi: 10.1016/j.trecan.2021.10.008

Bioactive mesoporous silica materials-assisted cancer immunotherapy. 2025;315:122919 doi: 10.1016/j.biomaterials.2024.122919

miRNAs as novel immunoregulators in cancer. 2022;124:3 doi: 10.1016/j.semcdb.2021.04.013

Recent advances and current challenges in CAR-T cell therapy. 2024;46:115 doi: 10.1007/s10529-023-03461-0

Precision Medicine in Oncology. 2020;133 doi: 10.1002/9781119432487.ch5

Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. 2023;15:2729 doi: 10.3390/cancers15102729

Challenges in Solid Tumors and Other Cancers: An Interdisciplinary Approach. 2024;21:213 doi: 10.1007/16833_2024_440

Pembrolizumab leading to complete resolution of non-small cell lung cancer and microsatellite instability stable colon adenocarcinoma; two birds one stone. 2022;8:20 doi: 10.5348/100111Z10PB2022CR

Space-velocity thermostatted kinetic theory model of tumor growth. 2021;18:5525 doi: 10.3934/mbe.2021279

Emerging Antibodies in Cancer Therapy. 2023;3: doi: 10.1002/anbr.202200083

Cell density quantification with TurboSPI: R2* mapping with compensation for off-resonance fat modulation. 2020;33:469 doi: 10.1007/s10334-019-00817-4

Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives. 2021;19: doi: 10.1186/s12951-021-00861-0

Cancer Biology and Advances in Treatment. 2020;1292:113 doi: 10.1007/5584_2020_522

Injectable immunogel based on polymerized phenylboronic acid and mannan for cancer immunotherapy. 2022;345:138 doi: 10.1016/j.jconrel.2022.03.009

Functionalized Poly(ethylene Glycol) Diacrylate Scaffolds for In Situ Immunomodulation of Dendritic Cells Targeting Melanoma Tumor. 2025;11:2396 doi: 10.1021/acsbiomaterials.4c02036

Recent advances in sialic acid-based active targeting chemoimmunotherapy promoting tumor shedding: a systematic review. 2024;16:14621 doi: 10.1039/D4NR01740D

Handbook of Microbial Nanotechnology. 2022;17 doi: 10.1016/B978-0-12-823426-6.00004-8

Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System. 2022;10:1842 doi: 10.3390/biomedicines10081842

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice. 2018;50:1 doi: 10.1038/s12276-018-0115-0

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy. 2020;9:2967 doi: 10.3390/jcm9092967

Principles of Tumors. 2020;453 doi: 10.1016/B978-0-12-816920-9.00018-3

CRISPR/Cas9 for Cancer Therapy: Hopes and Challenges. 2018;6:105 doi: 10.3390/biomedicines6040105

Bioactive Nanoparticles for Cancer Immunotherapy. 2018;19:3877 doi: 10.3390/ijms19123877

Cancer Treatment: An Interdisciplinary Approach. 2023;2:185 doi: 10.1007/16833_2023_166

Peptide-based targeting of immunosuppressive cells in cancer. 2020;5:92 doi: 10.1016/j.bioactmat.2020.01.006

Computational Methods in Drug Discovery and Repurposing for Cancer Therapy. 2023;237 doi: 10.1016/B978-0-443-15280-1.00018-2

Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis. 2020;106:104722 doi: 10.1016/j.oraloncology.2020.104722

The Golden Guide to Oncologic Pharmacy. 2022;243 doi: 10.1007/978-3-030-98596-7_7

Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review. 2024;41: doi: 10.1007/s12032-024-02337-1

Studying the Anticancer Effects of Thymoquinone on Breast Cancer Cells through Natural Killer Cell Activity. 2022;2022: doi: 10.1155/2022/9218640

Principles of Translational Science in Medicine. 2021;307 doi: 10.1016/B978-0-12-820493-1.00033-7

An overview of breast cancer in Pakistan. 2024;1: doi: 10.1007/s44337-024-00089-5

Biomaterials for Cancer Therapeutics. 2020;331 doi: 10.1016/B978-0-08-102983-1.00012-0

The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors. 2022;34:189 doi: 10.3233/CBM-210349

From concept to cure: The evolution of CAR-T cell therapy. 2025;33:2123 doi: 10.1016/j.ymthe.2025.03.005

Immunostimulatory biomaterials to boost tumor immunogenicity. 2020;8:5516 doi: 10.1039/D0BM01183E

Cancer Treatment: An Interdisciplinary Approach. 2023;2:1 doi: 10.1007/16833_2022_116

Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response. 2023;31:1 doi: 10.3390/curroncol31010001

Biomedical Nanotechnology. 2025;2902:107 doi: 10.1007/978-1-0716-4402-7_6

Cancers in Different Conditions, Cancer Research Methods and Diagnosis: An Interdisciplinary Approach. 2024;19:493 doi: 10.1007/16833_2024_422

Macrophage-centered therapy strategies: a promising weapon in cancer immunotherapy. 2025;101063 doi: 10.1016/j.ajps.2025.101063

Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams. 2022;31:2357 doi: 10.1007/s11136-022-03110-5

Aptamers based targeted drug delivery system: A newer trend in cancer treatment therapy. 2024;11:97 doi: 10.18231/j.jpbs.2023.016

Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates. 2022;13: doi: 10.3389/fimmu.2022.852147

Genetically Engineered T Cells and Recombinant Antibodies to Target Intracellular Neoantigens: Current Status and Future Directions. 2024;25:13504 doi: 10.3390/ijms252413504

An in-depth review of AI-powered advancements in cancer drug discovery. 2025;1871:167680 doi: 10.1016/j.bbadis.2025.167680

Cancer and the Immune System: The History and Background of Immunotherapy. 2019;35:150923 doi: 10.1016/j.soncn.2019.08.002

Biotechnology and Drug Development for Targeting Human Diseases. 2024;9:165 doi: 10.2174/9789815223163124090010

Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. 2022;346:43 doi: 10.1016/j.jconrel.2022.04.007

Therapeutic cancer vaccines: Where do we stand?. 2023;1:158 doi: 10.4103/jimr.jimr_28_23

Organic Afterglow Nanoparticles in Bioapplications. 2023;29: doi: 10.1002/chem.202301209

Advances and prospects of RNA delivery nanoplatforms for cancer therapy. 2025;15:52 doi: 10.1016/j.apsb.2024.09.009

Integrative Nanomedicine for New Therapies. 2020;321 doi: 10.1007/978-3-030-36260-7_12

The second near-infrared window quantum dot-based fluorescence anisotropy probes for separation-free, sensitive and rapid detection of small extracellular vesicle PD-L1 in plasma samples. 2023;376:132962 doi: 10.1016/j.snb.2022.132962

Cell-based Cancer Immunotherapy. 2024;183:355 doi: 10.1016/bs.mcb.2023.04.002

Immunosuppression. 2020; doi: 10.5772/intechopen.94754

Cancer Immunotherapy: Diverse Approaches and Obstacles. 2022;28:2387 doi: 10.2174/1381612828666220728160519

Metal-based immunogenic cell death inducers for cancer immunotherapy. 2025;16:6160 doi: 10.1039/D4SC08495K

Targeting cancer-associated glycans as a therapeutic strategy in leukemia. 2022;15:378 doi: 10.1080/26895293.2022.2049901

Synergistic Antitumor Effect of Combined Radiotherapy and Engineered Salmonella typhimurium in an Intracranial Sarcoma Mouse Model. 2023;11:1275 doi: 10.3390/vaccines11071275

Enriched pathways in gut microbiome predict response to immune checkpoint inhibitor treatment across demographic regions and various cancer types. 2025;28:112162 doi: 10.1016/j.isci.2025.112162

Emerging Immunotherapeutic and Diagnostic Modalities in Carcinoid Tumors. 2023;28:2047 doi: 10.3390/molecules28052047

The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy. 2021;70:98 doi: 10.1016/j.semcancer.2020.07.012

A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer. 2022;13: doi: 10.3389/fimmu.2022.845217

Tumor Microenvironment Regulates Immune Checkpoints: Emerging Need of Combinatorial Therapies. 2024;5:1 doi: 10.1007/s43152-023-00052-z

Cancer Vaccines: A Novel Revolutionized Approach to Cancer Therapy. 2025;40:191 doi: 10.1007/s12291-024-01201-3

William B. Coley. 2020;47:413 doi: 10.1016/j.ucl.2020.07.001

Analysis of tumor-immune functional responses in a mathematical model of neoantigen cancer vaccines. 2023;356:108966 doi: 10.1016/j.mbs.2023.108966

CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies. 2020;19:191 doi: 10.1093/bfgp/elz039

Picolylamine-functionalized benz[e]indole squaraine dyes: Synthetic approach, characterization and in vitro efficacy as potential anticancer phototherapeutic agents. 2022;229:114071 doi: 10.1016/j.ejmech.2021.114071

Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy. 2022;52:415 doi: 10.1007/s40005-022-00569-9

Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations. 2023;15:608 doi: 10.3390/hematolrep15040063

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy. 2023;13: doi: 10.1038/s41598-023-39365-2

Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications. 2021;22:166 doi: 10.1016/j.omto.2021.08.005

Over 132 Years Ago, the Inaugural Immunotherapy Treated Its First Head and Neck Cancer Patient. 2024;171:621 doi: 10.1002/ohn.745

Next-generation cancer vaccines and emerging immunotherapy combinations. 2024;10:749 doi: 10.1016/j.trecan.2024.06.003

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy. 2024; doi: 10.1111/bph.16304

Nanotherapeutics in Cancer Vaccination and Challenges. 2022;295 doi: 10.1016/B978-0-12-823686-4.00019-7

Overcoming neutrophil-induced immunosuppression in postoperative cancer therapy: Combined sialic acid-modified liposomes with scaffold-based vaccines. 2024;19:100906 doi: 10.1016/j.ajps.2024.100906

Advances in cancer immunotherapy: historical perspectives, current developments, and future directions. 2025;24: doi: 10.1186/s12943-025-02305-x

Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment. 2020;6:29 doi: 10.1007/s40883-019-00113-6

Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas. 2020;12:432 doi: 10.3390/cancers12020432

The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. 2023;34:783 doi: 10.1097/CAD.0000000000001463

Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. 2022;23:127 doi: 10.1080/15384047.2022.2033057

Immune System Efficiency in Cancer and the Microbiota Influence. 2021;88:170 doi: 10.1159/000512326

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?. 2023;13: doi: 10.3389/fonc.2023.1296906

Immunotherapy: an alternative promising therapeutic approach against cancers. 2022;49:9903 doi: 10.1007/s11033-022-07525-8

Cancer Treatment: An Interdisciplinary Approach. 2023;2:117 doi: 10.1007/16833_2022_64

Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT-CRP Induces Selective ROS-Dependent Apoptosis in T-Acute Lymphoblastic Leukemia Cell Lines. 2020;2020:1 doi: 10.1155/2020/1598503

Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma. 2021;12: doi: 10.3389/fgene.2021.744304

Cell membrane coated-nanoparticles for cancer immunotherapy. 2022;12:3233 doi: 10.1016/j.apsb.2022.02.023

PostFocus: automated selective post-acquisition high-throughput focus restoration using diffusion model for label-free time-lapse microscopy. 2024;40: doi: 10.1093/bioinformatics/btae467

Challenges and Opportunities of Gene Therapy in Cancer. 2024;08:1 doi: 10.21926/obm.genet.2401219

Editorial. 2020;43:5 doi: 10.1159/000510546

Tracing New Landscapes in the Arena of Nanoparticle-Based Cancer Immunotherapy. 2022;4: doi: 10.3389/fnano.2022.911063

Novel vaccines against lung cancer. 2025;37:73 doi: 10.1097/CCO.0000000000001102

The emergence of drug resistance to targeted cancer therapies: Clinical evidence. 2019;47:100646 doi: 10.1016/j.drup.2019.100646

Historical perspective and future directions: computational science in immuno-oncology. 2024;12:e008306 doi: 10.1136/jitc-2023-008306

Emerging druggable targets for immune checkpoint modulation in cancer immunotherapy: the iceberg lies beneath the surface. 2024;29:1879 doi: 10.1007/s10495-024-02022-8

Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated—A Systematic Review. 2022;2022: doi: 10.1155/2022/8549532

Recent Advances in Localized Immunotherapy of Skin Cancers. 2019;11:443 doi: 10.2217/imt-2018-0139

Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies. 2023;159:114243 doi: 10.1016/j.biopha.2023.114243

Neuromodulation by the immune system: implications for brain-directed immunotherapy. 2025;95:102568 doi: 10.1016/j.coi.2025.102568

Checkpoint inhibitors: What gastroenterologists need to know. 2018;24:5433 doi: 10.3748/wjg.v24.i48.5433

Pembrolizumab: The Nut Cracker. 2020;41:393 doi: 10.4103/ijmpo.ijmpo_37_20

Biomaterial Based Approaches to Study the Tumour Microenvironment. 2022;342 doi: 10.1039/9781839166013-00342

Handbook of Cancer and Immunology. 2022;1 doi: 10.1007/978-3-030-80962-1_183-1

Ecology of Fear: Spines, Armor and Noxious Chemicals Deter Predators in Cancer and in Nature. 2021;9: doi: 10.3389/fevo.2021.682504

The role of Globo H and SSEA-4 in the Development and Progression of Cancer, and their Potential as Therapeutic Targets. 2022;18:117 doi: 10.2217/fon-2021-1110

Active immunotherapy of cancer: An overview of therapeutic vaccines. 2019;69:490 doi: 10.5937/arhfarm1906490F

Phytosome-based nanotechnology for enhanced efficacy of anticancer phytocompounds: Challenges and prospects. 2025;104:106543 doi: 10.1016/j.jddst.2024.106543

Combined strategies for tumor immunotherapy with nanoparticles. 2019;21:1441 doi: 10.1007/s12094-019-02081-3

Modeling immune cell behavior across scales in cancer. 2020;12: doi: 10.1002/wsbm.1484

Brain Tumors: Development, Drug Resistance, and Sensitization – An Epigenetic Approach. 2023;18: doi: 10.1080/15592294.2023.2237761

Immunotherapy and other systemic therapies for cutaneous SCC. 2019;99:104459 doi: 10.1016/j.oraloncology.2019.104459

Fatty Acid Metabolism and Cancer Immunotherapy. 2022;24:659 doi: 10.1007/s11912-022-01223-1

Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy. 2022;22: doi: 10.4110/in.2022.22.e3

On the development of a neoantigen vaccine for the prevention of Lynch Syndrome. 2022;151:107 doi: 10.1002/ijc.33971

O-acetylated Gangliosides as Targets for Cancer Immunotherapy. 2020;9:741 doi: 10.3390/cells9030741

Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection. 2020;20: doi: 10.1186/s12874-020-00997-x

Cancer Vaccines. 2025;2926:15 doi: 10.1007/978-1-0716-4542-0_2

E. coli as a Smart Thermo-Vector for Combating Solid Tumors: A Synergistic Heat-Induced Cancer Therapy Approach. 2025;36:867 doi: 10.1021/acs.bioconjchem.5c00102

Current Immunotherapy Treatments of Primary Breast Cancer Subtypes. 2024;12:895 doi: 10.3390/biomedicines12040895

Biosimilars for Cancer Treatment. 2024;15 doi: 10.1007/978-981-97-3001-8_2

The Landscape of Nanovectors for Modulation in Cancer Immunotherapy. 2022;14:397 doi: 10.3390/pharmaceutics14020397

Efficacy of immunotherapy with PD-1 inhibitor in colorectal cancer: a meta-analysis. 2020;9:1285 doi: 10.2217/cer-2020-0040

An Overview on Immunogenic Cell Death in Cancer Biology and Therapy. 2022;14:1564 doi: 10.3390/pharmaceutics14081564

Update on Mesenchymal Stem Cells: A Crucial Player in Cancer Immunotherapy. 2024;24:98 doi: 10.2174/1566524023666221226143814

Burger's Medicinal Chemistry and Drug Discovery. 2021;1 doi: 10.1002/0471266949.bmc157.pub2

Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma. 2022;12:2820 doi: 10.1158/2159-8290.CD-22-0196

Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. 2022;39 doi: 10.1016/B978-0-323-90461-2.00001-8

A guide to cancer immunotherapy: from T cell basic science to clinical practice. 2020;20:651 doi: 10.1038/s41577-020-0306-5

Nanoformulation Strategies for Cancer Treatment. 2021;207 doi: 10.1016/B978-0-12-821095-6.00003-3

Humanized Germ-Free Mice for Investigating the Intervention Effect of Commensal Microbiome on Cancer Immunotherapy. 2022;37:1291 doi: 10.1089/ars.2022.0039

Translational Biotechnology. 2021;233 doi: 10.1016/B978-0-12-821972-0.00014-9

The prospects of cell therapy for endometriosis. 2023;40:955 doi: 10.1007/s10815-023-02772-5

Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities. 2025;17:1691 doi: 10.3390/cancers17101691

Microsatellite Instability in Russian Patients with Colorectal Cancer. 2022;23:7062 doi: 10.3390/ijms23137062

Automated detection of apoptotic bodies and cells in label-free time-lapse high-throughput video microscopy using deep convolutional neural networks. 2023;39: doi: 10.1093/bioinformatics/btad584

From Cell–Cell Interaction to Stochastic and Deterministic Descriptions of a Cancer–Immune System Competition Model. 2023;11:2188 doi: 10.3390/math11092188

Coley’s Toxin to First Approved Therapeutic Vaccine—A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment. 2024;12:2746 doi: 10.3390/biomedicines12122746

Nanoparticles: Properties and Applications in Cancer Immunotherapy. 2019;25:1962 doi: 10.2174/1381612825666190708214240